Upper Airway Training for Treatment of Snoring

November 6, 2017 updated by: University of Minnesota

Upper Airway Training for Treatment of Snoring Using Smartphone Application

The objective of this study is to reduce the incidence or intensity of snoring in a patient population of known simple snorers without sleep apnea using smartphone based application which allows participants to play voice controlled games using various articulations resulting in tongue base movements.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Fluent in English.
  2. Age is between 20 and 65.
  3. BMI less than 32
  4. Less than 5% variance in weight since sleep study.
  5. Snoring without health risk related to sleep apnea and not currently receiving treatment.

    1. Mild OSA or negative HSAT or PSG within past year with AHI 0-14
    2. Has refused oral appliances, CPAP, weight loss, surgery or positional therapy.
  6. Owns an iPhone 4 or newer and is comfortable downloading and using apps.
  7. Complaint of habitual snoring 3 or more nights per week
  8. Rated by polysomnograph technologist as moderate or loud snoring.

Exclusion Criteria:

  1. Non-fluent in English.
  2. Persistent rhinitis diagnosis or nasal obstruction.
  3. BMI > 32
  4. Greater than 5% variance in weight since sleep study.
  5. Diagnosis of moderate to severe sleep apnea or any other sleep disorder (insomnia, RLS)
  6. Insufficient sleep, defined as getting fewer than 6 hours of sleep on an average night based on self report.
  7. Spouse/partner is also a habitual snorer.
  8. Lacking ability to consent for themselves.
  9. Heavy drinker (self reported average more than 2 drinks per day).
  10. Regular narcotics (greater than 3 times/week)
  11. Epworth sleepiness scale score > 11 or one near miss accident in the past 6 months.
  12. Medical conditions as follows: symptomatic cardiopulmonary disease, chronic renal insufficiency, poorly controlled mental illness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Voice controlled smart phone game play 15 minutes daily and recording sounds of sleep environment 2 night per week for 12 weeks
Active Comparator: Control
Recording of sleep environment 2 nights per week for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Snoring Intensity
Time Frame: 12 weeks
Snoring sounds >60 db
12 weeks
Snoring Rate
Time Frame: 12 weeks
Snoring sounds/hour of sleep
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep Quality
Time Frame: 12 weeks
Self reported sleep quality on likert scale (0 to 5)
12 weeks
Bed Partner Sleep Quality
Time Frame: 12 weeks
Bed partner reported sleep quality on likert scale (0 to 5)
12 weeks
Sleepiness
Time Frame: 12 weeks
Epworth sleepiness score
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2016

Primary Completion (Actual)

April 15, 2017

Study Completion (Actual)

May 18, 2017

Study Registration Dates

First Submitted

August 23, 2017

First Submitted That Met QC Criteria

August 24, 2017

First Posted (Actual)

August 29, 2017

Study Record Updates

Last Update Posted (Actual)

November 8, 2017

Last Update Submitted That Met QC Criteria

November 6, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 1606S88671

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Snoring

Clinical Trials on Control

3
Subscribe